TrialClinical breast cancer2012

North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.

Kostandinos Sideras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.